On Thursday, Lilly(Eli) & Co (NYSE: LLY) was 14.30% up from the session before settling in for the closing price of $734.90. A 52-week range for LLY has been $677.09 – $972.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 15.54%. When this article was written, the company’s average yearly earnings per share was at 75.73%. With a float of $849.99 million, this company’s outstanding shares have now reached $947.54 million.
Let’s determine the extent of company efficiency that accounts for 47000 employees. In terms of profitability, gross margin is 81.62%, operating margin of 36.65%, and the pretax margin is 28.15%.
Lilly(Eli) & Co (LLY) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Lilly(Eli) & Co stocks. The insider ownership of Lilly(Eli) & Co is 10.34%, while institutional ownership is 73.04%. The most recent insider transaction that took place on Mar 13 ’25, was worth 1,643,720. Before that another transaction happened on Mar 13 ’25, when Company’s SVP, Finance, & CAO sold 1,000 for $818.24, making the entire transaction worth $818,240. This insider now owns 5,840 shares in total.
Lilly(Eli) & Co (LLY) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 5.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.90% during the next five years compared to 18.77% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
You can see what Lilly(Eli) & Co (LLY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.68. Likewise, its price to free cash flow for the trailing twelve months is 211.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.49, a number that is poised to hit 3.84 in the next quarter and is forecasted to reach 29.73 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Looking closely at Lilly(Eli) & Co (NYSE: LLY), its last 5-days average volume was 4.74 million, which is a jump from its year-to-date volume of 3.81 million. As of the previous 9 days, the stock’s Stochastic %D was 69.98%. Additionally, its Average True Range was 39.31.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 63.00%, which indicates a significant decrease from 90.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.83% in the past 14 days, which was higher than the 39.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $835.66, while its 200-day Moving Average is $847.18. However, in the short run, Lilly(Eli) & Co’s stock first resistance to watch stands at $858.03. Second resistance stands at $876.09. The third major resistance level sits at $894.19. If the price goes on to break the first support level at $821.87, it is likely to go to the next support level at $803.77. Now, if the price goes above the second support level, the third support stands at $785.71.
Lilly(Eli) & Co (NYSE: LLY) Key Stats
There are 948,170K outstanding shares of the company, which has a market capitalization of 796.27 billion. As of now, sales total 45,043 M while income totals 10,590 M. Its latest quarter income was 13,533 M while its last quarter net income were 4,410 M.
